Zusammenfassung
Asthma ist eine chronisch entzündliche Erkrankung der Atemwege. Pathogenetisch steht die allergeninduzierte Atemwegsentzündung im Vordergrund. Infektionen spielen aber eine wesentliche Rolle als Auslöser akuter Exazerbationen und kommen auch in einer chronisch oder latenten Form als Verstärker der lokalen Entzündungsreaktion in Betracht. Ziel dieses Beitrags ist es, eine Übersicht über die unterschiedlichen Infektionserreger zu geben und den aktuellen Wissensstand zur Bedeutung von Atemwegsviren und atypischen Bakterien (C. pneumoniae und M. pneumoniae) in der Pathogenese von Asthma darzustellen.
Abstract
Asthma is a chronic inflammatory disorder of the airways. Allergen-induced airway inflammation plays a central role in the pathogenesis of the disease whereas infections are known to be important triggers of acute exacerbations. Chronic or latent infections may also influence and enhance the local inflammation. The aim of this review is to give an overview of the different pathogens and to present the current understanding of the role of respiratory viruses and atypical bacteria in the pathogenesis of the disease.
Literatur
Bateman ED, Hurd SS, Barnes PJ et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143–178
Biscione GL, Corne J, Chauhan AJ, Johnston SL (2004) Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J 24: 745–749
Black PN, Blasi F, Jenkins CR et al. (2001) Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 164: 536–541
Brooks GD, Buchta KA, Swenson CA et al. (2003) Rhinovirus-induced Interferon-{gamma} and airway responsiveness in asthma. Am J Respir Crit Care Med 168: 1091–1094
Buhl R, Berdel D, Criee CP et al. (2006) Guidelines for diagnosis and treatment of asthma patients. Pneumologie 60: 139–177
Bunk S, Susnea I, Rupp J et al. (2008) Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J Immunol 180: 5490–5498
Carlsen KH, Orstavik I, Leegaard J, Hoeg H (1984) Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child 59: 310–315
Chu HW, Honour JM, Rawlinson CA et al. (2003) Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 71: 1520–1526
Contoli M, Message SD, Laza-Stanca V et al. (2006) Role of deficient type III interferon-[lambda] production in asthma exacerbations. Nat Med 12: 1023–1026
Copenhaver CC, Gern JE, Li Z et al. (2004) Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 170: 175–180
Corne JM, Marshall C, Smith S et al. (2002) Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359: 831–834
Cosentini R, Tarsia P, Canetta C et al. (2008) Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 9: 48
Cunha BA (2008) The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins. Eur J Clin Microbiol Infect Dis [Epub ahead of print]
Daxboeck F, Krause R, Wenisch C (2003) Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 9: 263–273
Dowell SF, Peeling RW, Boman J et al. (2001) Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33: 492–503
Falck G, Gnarpe J, Hansson LO et al. (2002) Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 122: 1587–1593
Fraenkel DJ, Bardin PG, Sanderson G et al. (1995) Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 151: 879–886
Gehlhar K, Bilitewski C, Reinitz-Rademacher K et al. (2006) Impaired virus induced IFN-α release in adult asthmatic patients. Clin Exp Allergy 36: 331–337
Gern JE, Brooks GD, Meyer P et al. (2006) Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 117: 72–78
Gern JE, Galagan DM, Jarjour NN et al. (1997) Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155: 1159–1161
Gern JE, Vrtis R, Grindle KA et al. (2000) Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 162: 2226–2231
Grissell TV, Powell H, Shafren DR et al. (2005) IL-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 172: 433–439
Grunberg K, Sharon RF, Hiltermann TJ et al. (2000) Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin Exp Allergy 30: 1015–1023
Grunberg K, Sharon RF, Sont JK et al. (2001) Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 164: 1816–1822
Grunberg K, Smits HH, Timmers MC et al. (1997) Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 156: 609–616
Grunberg K, Timmers MC, de Klerk EP et al. (1999) Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 160: 1375–1380
Harju TH, Leinonen M, Nokso-Koivisto J et al. (2006) Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax 61: 579–584
Horvat JC, Beagley KW, Wade MA et al. (2007) Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176: 556–564
Huittinen T, Hahn D, Anttila T et al. (2001) Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J 17: 1078–1082
Jackson DJ, Gangnon RE, Evans MD et al. (2008) Wheezing rhinovirus illnesses in early life predict asthma development in high risk children. Am J Respir Crit Care Med 178: 667–672
Jarjour NN, Gern JE, Kelly EA et al. (2000) The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol105: 1169–1177
Johnston NW, Johnston SL, Duncan JM et al. (2005) The September epidemic of asthma exacerbations in children: A search for etiology. J Allergy Clin Immunol 115: 132–138
Johnston SL, Blasi F, Black PN et al. (2006) The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354: 1589–1600
Johnston SL, Pattemore PK, Sanderson G et al. (1995) Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 310: 1225–1229
Johnston SL, Pattemore PK, Sanderson G et al. (1996) The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis. Am J Respir Crit Care Med 154: 654–660
Kaiko GE, Phipps S, Hickey DK et al. (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 180: 2225–2232
Kling S, Donninger H, Williams Z et al. (2005) Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 35: 672–678
Kraft M, Adler KB, Ingram JL et al. (2008) Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J 31: 43–46
Kraft M, Cassell GH, Pak J, Martin RJ (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121: 1782–1788
Kumar S, Hammerschlag MR (2007) Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 44: 568–576
Lieberman D, Lieberman D, Printz S et al. (2003) Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 167: 406–410
Lopez-Souza N, Dolganov G, Dubin R et al. (2004) Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 286: L373–L381
Martin RJ, Chu HW, Honour JM, Harbeck RJ (2001) Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 24: 577–582
Modrow S, Falke D, Truyen U (2003) Labormethoden zum Nachweis von Virusinfektionen. In: Modrow S, Falke D, Truyen U (Hrsg) Molekulare Virologie, 2. Aufl. Spektrum, Heidelberg Berlin, pp 114–129
Mosser AG, Brockman-Schneider R, Amineva S et al. (2002) Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 185: 734–743
Nicholson KG, Kent J, Ireland DC (1993) Respiratory viruses and exacerbations of asthma in adults. BMJ 307: 982–986
Nilsson AC, Bjorkman P, Persson K (2008) Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 8: 93
Papadopoulos NG, Bates PJ, Bardin PG et al. (2000) Rhinoviruses infect the lower airways. J Infect Dis 181: 1875–1884
Papadopoulos NG, Stanciu LA, Papi A et al. (2002) A defective type 1 response to rhinovirus in atopic asthma. Thorax 57: 328–332
Papi A, Johnston SL (1999) Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1á(ICAM-1) via increased NF-kappa B-mediated transcription. J Biol Chem 274: 9707–9720
Parchuri S, Cunha BA (2006) Mycoplasma pneumoniae community-acquired pneumonia: diagnostic usefulness of the bedside cold agglutinin agglutination-dissociation test. Infect Dis Pract30: 550–551
Rakes GP, Arruda E, Ingram JM et al. (1999) Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 159: 785–790
Schroth MK, Grimm E, Frindt P et al. (1999) Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 20: 1220–1228
Sheppard P, Kindsvogel W, Xu W et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63–68
Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161: 1501–1507
Spurrell JCL, Wiehler S, Zaheer RS et al. (2005) Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289: L85–95
Stein RT, Sherrill D, Morgan WJ et al. (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541–545
Stern DA, Guerra S, Halonen M et al. (2007) Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 120: 835–841
Subauste MC, Jacoby DB, Richards SM, Proud D (1995) Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96: 549–557
Tarlo S, Broder I, Spence L (1979) A prospective study of respiratory infection in adult asthmatics and their normal spouses. Clin Allergy 9: 293–301
Terajima M, Yamaya M, Sekizawa K et al. (1997) Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol 273: L749–L759
von Hertzen L, Vasankari T, Liippo K et al. (2002) Chlamydia pneumoniae and severity of asthma. Scand J Infect 34: 22–27
Wark PA, Johnston SL, Bucchieri F et al. (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201: 937–947
Wark PA, Johnston SL, Moric I et al. (2002) Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19: 68–75
Wark PA, Johnston SL, Simpson JL et al. (2002) Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J 20: 834–840
Winther B, Gwaltney JM Jr, Mygind N et al. (1986) Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256: 1763–1767
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rohde, G., Rupp, J. Infektion und Asthma. Internist 49, 1302–1310 (2008). https://doi.org/10.1007/s00108-008-2133-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-008-2133-9